QUINDOLINE

ID: ALA224248

Max Phase: Preclinical

Molecular Formula: C15H10N2

Molecular Weight: 218.26

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (2): 10H-Indolo[3,2-B]Quinoline | Quindoline
Synonyms from Alternative Forms(2):

    Canonical SMILES:  c1ccc2nc3c(cc2c1)[nH]c1ccccc13

    Standard InChI:  InChI=1S/C15H10N2/c1-3-7-12-10(5-1)9-14-15(17-12)11-6-2-4-8-13(11)16-14/h1-9,16H

    Standard InChI Key:  QOAKRWLMTKEDDL-UHFFFAOYSA-N

    Associated Targets(Human)

    Telomerase reverse transcriptase 2428 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    A2780 11979 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    CH1 841 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SK-OV-3 52876 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Plasmodium falciparum 966862 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Histidine-rich protein 528 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    L6 7924 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Trypanosoma cruzi 99888 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium yoelii 6656 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium berghei 192651 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Saccharomyces cerevisiae 19171 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 218.26Molecular Weight (Monoisotopic): 218.0844AlogP: 3.87#Rotatable Bonds: 0
    Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 12.91CX Basic pKa: 4.50CX LogP: 3.63CX LogD: 3.63
    Aromatic Rings: 4Heavy Atoms: 17QED Weighted: 0.48Np Likeness Score: -0.24

    References

    1. Caprio V, Guyen B, Opoku-Boahen Y, Mann J, Gowan SM, Kelland LM, Read MA, Neidle S..  (2000)  A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline.,  10  (18): [PMID:10999471] [10.1016/s0960-894x(00)00378-4]
    2. Wright CW, Addae-Kyereme J, Breen AG, Brown JE, Cox MF, Croft SL, Gökçek Y, Kendrick H, Phillips RM, Pollet PL..  (2001)  Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents.,  44  (19): [PMID:11543688] [10.1021/jm010929+]
    3. Arzel E, Rocca P, Grellier P, Labaeïd M, Frappier F, Guéritte F, Gaspard C, Marsais F, Godard A, Quéguiner G..  (2001)  New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines.,  44  (6): [PMID:11300877] [10.1021/jm0010419]
    4. Zhou JL, Lu YJ, Ou TM, Zhou JM, Huang ZS, Zhu XF, Du CJ, Bu XZ, Ma L, Gu LQ, Li YM, Chan AS..  (2005)  Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.,  48  (23): [PMID:16279791] [10.1021/jm050041b]
    5. Cimanga K, De Bruyne T, Pieters L, Vlietinck AJ, Turger CA..  (1997)  In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta.,  60  (7): [PMID:9249972] [10.1021/np9605246]
    6. Yang SW, Abdel-Kader M, Malone S, Werkhoven MC, Wisse JH, Bursuker I, Neddermann K, Fairchild C, Raventos-Suarez C, Menendez AT, Lane K, Kingston DG..  (1999)  Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest.,  62  (7): [PMID:10425120] [10.1021/np990035g]
    7. Nuthakki VK, Mudududdla R, Bharate SB..  (2022)  Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.,  227  [PMID:34710743] [10.1016/j.ejmech.2021.113938]

    Source